BioSpace News Archive

The poster (Board J1, Abstract #91) can be found online at Five Prime Therapeutics Scientific Publications.

Synairgen (LSE: SNG), the respiratory drug discovery and development company, is pleased to note that Pharmaxis has reported receipt of all data for the LOXL2 inhibitor candidates in three-month toxicity studies.

− Ebbers named Executive Vice President and General Manager, Dermatology − Tyson named Vice President, Sales North America

Actively enrolling up to 150 patients to evaluate lumen patency at one year obtained by arterial vessel preparation with the FLEX Vessel Preparation System prior to conventional endovascular recanalization of the superficial femoral artery (SFA) and popliteal artery (PA).

Adaptive Biotechnologies announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) and leader in assessing diagnostic technologies through its MolDX program, has established coverage of the clonoSEQ® Assay for Medicare patients with multiple myeloma and B-cell acute lymphoblastic leukemia (ALL).

SPAN℠-PD, the efficacy and safety study of INBRIJA (CVT-301), showed significant improvement in motor function during OFF periods in people with Parkinson’s on a carbidopa/levodopa regimen

MDA-Funded ONEVoice Survey of 3,000+ Patients and Caregivers Highlights Concerns and Solutions

Olive, the only healthcare-focused artificial intelligence and robotic process automation company, is pleased to announce the appointment of George S. Barrett, former chairman and chief executive officer of Cardinal Health, Inc. as a new director, effective immediately.

Nobel Laureates will discuss the Future of Learning on Jan. 19, 2019, during a Nobel Prize Dialogue event that will be held for the first time in Latin America.

HEAVEN Criteria is a life-saving airway management prediction tool to be studied and adopted by clinicians worldwide